EDXC Endexx Corporation (PK)

Endexx to Exhibit at Marijuana Business Conference & Expo 2014

Cave Creek, AZ- September 29, 2014 - InvestorsHub NewsWire - Endexx Corporation (OTC Pink: EDXC), a provider of innovative medical marijuana management and technology solutions, is pleased to announce that its Cannsumable division has received an initial shipment of 10 liters of high grade organic CBD (cannabidiol) rich hemp oil. Endexx has secured a high quality supply chain of pharmaceutical grade CBD-rich hemp oil for the immediate processing and distribution of Endexx’s proprietary nutraceutical products for the US market under the M3CBD and Cannsumable brands.
In line with its commitment to develop quality controls and the highest standards for the industry, Endexx is engaging with collaborative partners with scientific, medical and food industry expertise to assure that cost effective delivery systems are developed, manufactured and distributed under the strictest quality standards for purity, transparency, dosage accuracy and bioavailability.
 
According to findings from numerous experimental and clinical studies, the absorption ratio of CBD when administered orally is 6%, and 31% when smoked or inhaled.
 
The first Cannsummable product scheduled to be launched in October is a discreet vaporizer kit that includes a pen, 2 batteries, a USB port and 2 oil clearomizers with 40 milligrams of high grade CBD in an all-natural hemp oil base. The kit is presented in an attractive and user-friendly CannCan trademarked container. The first batches have been pre-sold and the kit has a suggested retail price of $120-150 USD.
 
Other products to be launched in the coming months include an organic frozen edibles and sublingual drops. In other future developments, recognizing the need for a wider body of research to help identify the potential therapeutic properties and role of CBD in alternative pain management, Endexx is planning to support a case study with medical patients suffering from diabetic neuropathy.
 
Endexx announced that it will be exhibiting at the Marijuana Business Conference & Expo in Las Vegas November 12-14. Endexx will feature the core M3Hub inventory tracking and management platform(Version 1.0), the Autospense inventory control and dispensing technology as well as the new line of CBD (cannabidiol) rich hemp oil products.
 
 
About Endexx 
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 -- the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com, www.autospense.com 
 
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
 
CONTACT:
For further investor and media information
Endexx Corporation
Todd Davis, Chairman & CEO 
endexx@endexx.com
480-595-6900

IRTH Communications
Robert Haag
Managing Director
edxc@irthcommunications.com 
866-976-4784
 

Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Dec 2024 to Jan 2025

Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Jan 2024 to Jan 2025